Davis Todd C - Insider Non-Derivative Transactions at LIGAND PHARMACEUTICALS INC (LGND) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 4, 2025, Davis Todd C's relationship to LIGAND PHARMACEUTICALS INC (LGND) is Director,Officer (Chief Executive Officer), and currently has 161,337 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LGND insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Davis Todd C - Insider Non-Derivative Transactions of LGND Common Stock

Davis Todd C - Insider Non-Derivative Transactions at LGND

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 5, 2025	G -- (Common Stock)	130	0	161337
Jul 1, 2025	J -- (Common Stock)	233	91.08	161467
May 10, 2025	P -- (Common Stock)	1680	104.57	153404
May 10, 2025	P -- (Common Stock)	2307	104.53	155711
May 10, 2025	P -- (Common Stock)	5523	105.67	161234
Mar 5, 2025	Acquisition -- (Common Stock)	21382	0	151724
Feb 16, 2025	F -- (Common Stock)	4255	120	130342
Feb 16, 2025	F -- (Common Stock)	2231	120	134597
Feb 15, 2025	F -- (Common Stock)	6966	120	136828
Feb 15, 2025	Acquisition -- (Common Stock)	20784	0	143794
Aug 9, 2024	P -- (Common Stock)	2500	97.39	123010
Jun 29, 2024	J -- (Common Stock)	350	60.71	120510
Mar 26, 2024	M -- (Common Stock)	7448	46.2	111593
Mar 26, 2024	M -- (Common Stock)	2855	67.24	114448
Mar 26, 2024	M -- (Common Stock)	2156	68.51	116604
Mar 26, 2024	M -- (Common Stock)	3556	66.19	120160
Feb 28, 2024	Acquisition -- (Common Stock)	32436	0	104145
Feb 16, 2024	F -- (Common Stock)	1381	74.65	71709
Sep 23, 2023	P -- (Common Stock)	4000	59.38	73090
Jun 10, 2023	F -- (Common Stock)	420	73.76	69090
Feb 24, 2023	Acquisition -- (Common Stock)	17005	0	68791